NASS DFNS CLASS OF 2026

Joost DeBruijn, PhD
Kuros Biosciences
Bilthoven, Netherlands
Researcher
NASS Member Since 2008
What initially inspired you to become involved with NASS, and what has kept you engaged over the years?
I became involved with NASS after developing an innovative bone graft for spinal fusion. Attending the annual meetings has deepened my understanding of clinical needs and the advantages and limitations of the various bone graft technologies surgeons use in daily practice. Compared with hardware such as screws and cages, the choice of bone graft often receives less attention, despite its critical role in achieving a solid bony fusion. I am therefore committed to helping surgeons better understand the differences among bone graft options, including their mechanisms of action, and to emphasizing the importance of robust clinical evidence over unsubstantiated marketing claims.
What accomplishment are you most proud of, and why?
The serendipitous discovery of MagnetOs bone graft twelve years ago and helping it grow to the third-largest bone graft technology by sales volume to date. This was driven by a strong scientific foundation and Kuros’ commitment to innovation and investment in Level 1 human clinical studies comparing MagnetOs to competing technologies, including a study demonstrating superiority to autograft.
How has your involvement with NASS influenced your professional growth or career journey?
Back in the early 1990’s, I was the drummer in an R&B band and was close to becoming professional before deciding to pursue my PhD in Biomedical Science instead.